Positions

Overview

  • Lori L. Davis, MD, is Clinical Professor of Psychiatry in the Department of Psychiatry and Behavioral Neurobiology, University of Alabama Health System, in Birmingham and Tuscaloosa, AL. In addition, she is Associate Chief of Staff for Research and Development Service for the VA Medical Center in Tuscaloosa, Alabama. Dr. Davis received her undergraduate degree in Studio Art from Duke University, earned her MD from the University of North Carolina at Chapel Hill, and completed a psychiatry residency at the University of Alabama at Birmingham.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2018 Reply to: It Is Time to Look for New Treatments for Posttraumatic Stress Disorder: Can Sympathetic System Modulation Be an Answer? 2018
    2017 It Is Time to Address the Crisis in the Pharmacotherapy of Posttraumatic Stress Disorder: A Consensus Statement of the PTSD Psychopharmacology Working Group 2017
    2017 An Evidence-Based Review of Early Intervention and Prevention of Posttraumatic Stress Disorder 2017
    2017 A Pilot Study of the Effects of Mindfulness-Based Stress Reduction on Post-traumatic Stress Disorder Symptoms and Brain Response to Traumatic Reminders of Combat in Operation Enduring Freedom/Operation Iraqi Freedom Combat Veterans with Post-traumatic Stress Disorder. 2017
    2016 An open label pilot study of adjunctive asenapine for the treatment of posttraumatic stress disorder 2016
    2016 What I have changed my mind about and why. 2016
    2014 Living Will Status and Desire for Living Will Help Among Rural Alabama Veterans 2014
    2014 Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder. 2014
    2014 Alabama Veterans Rural Health Initiative: a pilot study of enhanced community outreach in rural areas 2014
    2014 Alabama Veterans Rural Health Initiative: a pilot study of enhanced community outreach in rural areas 2014
    2014 Development of the primary care quality-homeless (PCQ-H) instrument: A practical survey of homeless patients' experiences in primary care 2014
    2014 Impact of social challenges on gaining employment for veterans with posttraumatic stress disorder: An exploratory moderator analysis 2014
    2013 Comparing homeless persons' care experiences in tailored versus nontailored primary care programs 2013
    2013 Internet connectivity among rural alabama veterans: Baseline findings from the alabama veterans rural health initiative project 2013
    2012 A randomized controlled trial of supported employment among veterans with posttraumatic stress disorder 2012
    2012 Internet connectivity among rural Alabama veterans: Baseline findings from the Alabama Veterans Rural Health Initiative Project 2012
    2011 Alabama Veterans Rural Health Initiative: A preliminary evaluation of Unmet Health Care Needs 2011
    2010 Indicators of pretreatment suicidal ideation in adults with major depressive disorder 2010
    2009 Concurrent anxiety and substance use disorders among outpatients with major depression: Clinical features and effect on treatment outcome 2009
    2008 Selecting among second-step antidepressant medication monotherapies: Predictive value of clinical, demographic, or first-step treatment features 2008
    2008 Divalproex in the treatment of posttraumatic stress disorder: A randomized, double-blind, placebo-controlled trial in a veteran population 2008
    2008 A placebo-controlled trial of guanfacine for the treatment of posttraumatic stress disorder in veterans. 2008
    2008 Clinical and pharmacoeconomic evaluation of switch to olanzapine in veterans with schizophrenia or schizoaffective disorder. 2008
    2008 Major depression and comorbid substance use disorders 2008
    2007 Pain in depression: STAR*D study findings 2007
    2007 A pharmacokinetic and clinical evaluation of switching patients with bipolar I disorder from delayed-release to extended-release divalproex 2007
    2007 Are depressed outpatients with and without a family history of substance use disorder different? A baseline analysis of the STAR*D cohort 2007
    2006 Substance use disorder comorbidity in major depressive disorder: A confirmatory analysis of the STAR*D cohort 2006
    2006 Long-term pharmacotherapy for post-traumatic stress disorder 2006
    2006 Enrolling research subjects from clinical practice: Ethical and procedural issues in the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial 2006
    2006 Treatment of chronic posttraumatic stress disorder in combat veterans with citalopram: An open trial 2006
    2005 Divalproex for the treatment of posttraumatic stress disorder: A retrospective chart review 2005
    2005 Substance use disorder comorbidity in major depressive disorder: An exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort 2005
    2004 Clonazepam for treatment of sleep disturbances associated with combat-related posttraumatic stress disorder 2004
    2004 A placebo-controlled study of nefazodone for the treatment of chronic posttraumatic stress disorder: A preliminary study 2004
    2004 Divalproex sodium in the treatment of adults with bipolar disorder 2004
    2000 Nefazodone treatment for chronic posttraumatic stress disorder: An open trial 2000
    1999 D-fenfluramine challenge in posttraumatic stress disorder 1999

    Research Overview

  • Since 1993, Dr. Davis has had consecutive peer-reviewed funding from the VA Merit, VA Rehabilitation R&D, Department of Defense and National Institute of Mental Health (NIMH), as well as investigator-initiated grants from pharmaceutical industry sources. For nearly a decade, Dr. Davis was Regional Site Director for the NIMH-funded study “Sequenced Treatment Alternatives to Relieve Depression (STAR*D)” and the subsequent Depression Trials Network. Her current research interests include the neurobiology, pharmacological and complementary alternative treatments, and vocational rehabilitation of posttraumatic stress disorder. Currently, she is Study Chair for the VA Cooperative Study Program (CSP#589) entitled “Veterans Individual Placement and Support Towards Advancing Recovery” (VIP-STAR), which is a multisite randomized controlled trial evaluating the efficacy of Individual Placement and Support supported employment in the vocational rehabilitation of unemployed Veterans with posttraumatic stress disorder (PTSD). In addition, Dr. Davis has recently completed a three-site randomized controlled trial of Mindfulness Based Stress Reduction (MBSR) meditation for the treatment of PTSD. She has been involved with numerous industry-sponsored treatment trials in mood and anxiety disorders.
  • Teaching Overview

  • Dr. Davis teaches medical students, psychiatry and family medicine residents, and public psychiatry fellows. She served as a member of the American Psychiatric Association Mood Disorders Workgroup on DSM-5 Revisions. She is a member of the 2017 VA-DoD workgroup for the revision of the Clinical Practice Guidelines for PTSD.
  • Education And Training

    Full Name

  • Lori Davis